Pamela J Hodul

Summary

Affiliation: H. Lee Moffitt Cancer Center and Research Institute
Country: USA

Publications

  1. ncbi Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?
    Pamela J Hodul
    Gastrointestinal Tumor Program, Departmentsof Surgery, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 15:314-21. 2008
  2. ncbi Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications
    Jonathan R Strosberg
    Department of GI Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA
    Ann Surg 256:321-5. 2012
  3. ncbi Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer
    Jong Y Park
    Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Pancreas 36:e32-9. 2008
  4. ncbi Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution
    James F Helm
    Gastrointestinal Tumor Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 15:288-94. 2008
  5. ncbi Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy
    Sean P Barnett
    Department of Surgery and Biostatistics, Loyola Stritch School of Medicine, Maywood, Illinois, USA
    Am Surg 70:222-6; discussion 227. 2004
  6. ncbi Zero mortality after 152 consecutive pancreaticoduodenectomies with pancreaticogastrostomy
    Gerard V Aranha
    Section of Surgical Oncology, Hines VA Hospital, Maywood, IL 60153, USA
    J Am Coll Surg 197:223-31; discussion 231-2. 2003

Collaborators

Detail Information

Publications6

  1. ncbi Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?
    Pamela J Hodul
    Gastrointestinal Tumor Program, Departmentsof Surgery, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 15:314-21. 2008
    ..This paper discusses whether aggressive surgical intervention is indicated for PNETs and investigates what prognostic factors may assist in predicting which patients with invasive disease will benefit most from surgical intervention...
  2. ncbi Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications
    Jonathan R Strosberg
    Department of GI Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA
    Ann Surg 256:321-5. 2012
    ....
  3. ncbi Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer
    Jong Y Park
    Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Pancreas 36:e32-9. 2008
    ....
  4. ncbi Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution
    James F Helm
    Gastrointestinal Tumor Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 15:288-94. 2008
    ....
  5. ncbi Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy
    Sean P Barnett
    Department of Surgery and Biostatistics, Loyola Stritch School of Medicine, Maywood, Illinois, USA
    Am Surg 70:222-6; discussion 227. 2004
    ..026). Octreotide did not reduce pancreatic fistula, other complications, or mortality. Octreotide may contribute cardiac morbidity. Octreotide cannot be recommended to prevent mortality or postoperative complications after PD...
  6. ncbi Zero mortality after 152 consecutive pancreaticoduodenectomies with pancreaticogastrostomy
    Gerard V Aranha
    Section of Surgical Oncology, Hines VA Hospital, Maywood, IL 60153, USA
    J Am Coll Surg 197:223-31; discussion 231-2. 2003
    ..With proper selection, careful preoperative preparation, and proper intraoperative conduct of operation, the Whipple procedure can be performed without postoperative mortality...